The demonstration that IL-34 stimulates IL-6 induction in both TICs and LPMCs supports further the protumorigenic role of IL-34, as IL-6 can target directly cancer cells and activate signaling pathways that promote CRC cell growth and survival25,26. The gene discussed is IL34; the disease is colorectal carcinoma.